Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Autoimmune Liver Disease
How do you manage liver enzyme elevations in patients with PBC after starting elanifibranor?
Related Questions
What is your approach to the management of anti-pruritic therapies in patients with cholestatic liver disease?
What patient factors guide your selection of maintenance therapies for a patient with auto-immune hepatitis?
How do you approach restarting immunotherapy in a patient with metastatic melanoma who previously developed immune-mediated hepatitis (Grade 3), with liver enzymes now back to baseline levels?
What is your approach to treatment of immune-mediated overlap syndromes, such as AIH-PBC?
How do you prefer to manage IgG-4 related hepato-biliary disease, especially if there are similarities in imaging findings to other immune mediated liver diseases?
What are your biggest takeaways from the MASH-TAG 2025 conference?
How do you determine when you would treat an identified spleno-renal shunt and how?
How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?
What management considerations do you keep in mind in the management of pregnant patients with autoimmune liver disease?
How do you utilize Cystatin-C as a marker of renal dysfunction in patients with chronic liver disease?
